Form 8-K - Current report:
SEC Accession No. 0001628280-24-000776
Filing Date
2024-01-08
Accepted
2024-01-08 08:42:02
Documents
14
Period of Report
2024-01-08
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K blfs-20240108.htm   iXBRL 8-K 25345
2 EX-99.1 a991-q42023preliminaryreve.htm EX-99.1 17985
6 GRAPHIC imagea.jpg GRAPHIC 78528
  Complete submission text file 0001628280-24-000776.txt   281249

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blfs-20240108.xsd EX-101.SCH 1928
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blfs-20240108_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blfs-20240108_pre.xml EX-101.PRE 12526
8 EXTRACTED XBRL INSTANCE DOCUMENT blfs-20240108_htm.xml XML 2719
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

EIN.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36362 | Film No.: 24518551
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)